55 results on '"Erler D"'
Search Results
2. Stereotactic Body Radiotherapy for Renal Cell Carcinoma: Oncological and Renal Function Outcomes
3. Stereotactic Body Radiation Therapy for Non-Spine Bone Metastases: Local Control and Fracture Risk
4. Outcomes of Extracranial Oligorecurrence after Prior Metastases Directed Stereotactic Body Radiotherapy for Oligometastatic Disease
5. Multi-Target Thoracic Stereotactic Body Radiotherapy – Toxicity and Efficacy Analysis
6. Stereotactic Body Radiotherapy for Metastases to the Head and Neck
7. Does Local Failure Following Oligometastasis-Directed SBRT Predict for Widespread Progression and Overall Survival?
8. OC-0768 Stereotactic body radiotherapy for renal cell carcinoma: oncologic and renal function outcomes
9. MO-0713 Stereotactic Body Radiotherapy for Long Bone Metastases: An International Multicenter Analysis
10. SP-1021 Reimagining on-treatment radiation review clinics: Bringing the patient voice to the forefront and delivering the right care at the right time
11. Outcomes and toxicities in oligometastatic patients treated with stereotactic body radiotherapy for adrenal gland metastases: A multi-institutional retrospective study
12. A Prognostic Model for Patients With Oligometastatic Disease Treated With Stereotactic Body Radiation Therapy
13. Outcomes for Oligometastatic Head and Neck Cancer Undergoing SBRT: Results From an International Multi-Institutional Consortium
14. Biochemical Failure and Toxicity of Magnetic Resonance Imaging Dose Painting to Dominant Intraprostatic Lesion in Prostate High Dose Rate Brachytherapy
15. Outcomes and Toxicities in Oligometastatic Patients Treated With Stereotactic Body Radiotherapy for Adrenal Gland Metastases: A Multi-Institutional Study
16. Impact of Volumetric Burden of Metastatic Lesions on Outcomes in Extracranial Oligometastatic Patients: A Multi-Institutional Study
17. Role of Stereotactic Body Radiotherapy (SBRT) in the Treatment of Oligo Metastatic Colorectal Cancer: Analysis of a Large Multi-Institutional Database
18. OC-0316 Knowledge and skills for MRI in radiotherapy practice: An international modified Delphi study
19. PD-0845 Stereotactic radiotherapy for oligometastatic NSCLC: results from the multicenter CORE consortium.
20. Patient-reported Quality of Life following Stereotactic Body Radiation Therapy for Primary Kidney Cancer – Results from a Prospective Cohort Study
21. SBRT For Head and Neck Skin Cancer: An Initial Experience in 106 Medically Unfit Patients
22. SBRT for Oligometastatic Non-Spine Bone Metastases: A Multi-Institutional Study
23. Stereotactic Ablative Radiotherapy (SABR) in Oligometastatic and Oligoprogressive Gynecologic Cancers: Clinical Outcomes of a Single Institution Analysis
24. An International Multi-Institutional Pooled Analysis of 1033 Extra-Cranial Oligometastatic Patients Treated with Definitive Stereotactic Body Radiotherapy (SBRT)
25. Conditional Survival of Extracranial Oligometastatic Patients Treated with Stereotactic Body Radiation Therapy (SBRT): An International Consortium Study
26. A Multi-Institutional Retrospective Clinical and Dosimetric Analyses of 1033 Oligometastatic Patients Treated with SBRT from the Consortium for Oligometastases Research - CORE
27. Evaluating Respiratory Motion of the Bony Thorax in the Context of Stereotactic Body Radiation Therapy (SBRT)
28. Comprehensive Stereotactic Radiotherapy for Oligometastatic Prostate Cancer (CROP)
29. Patient-Reported Quality of Life Following Stereotactic Body Radiation Therapy for Primary Kidney Cancer: Results from a Prospective Cohort Study
30. Stereotactic Body Radiation Therapy (SBRT) for Adrenal Metastasis Provides More than Local Control
31. Identifying Potential Predictors of Late Renal Toxicity after Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: A Prospective Cohort Study
32. Outcomes and Toxicity of Stereotactic Radiation Therapy for Metastatic Breast Cancer – A Retrospective Cohort Study
33. Stereotactic Body Radiation Therapy for Metastatic Colorectal Cancer: Comprehensive Review from a Large Academic Institution
34. PO-0833: Dosimetric analysis of renal toxicity after stereotactic body radiotherapy for renal cell carcinoma
35. Stereotactic Body Radiotherapy (SBRT) Boost to Mimic High-Dose Rate (HDR) Brachytherapy Boost for Intermediate Risk Prostate Cancer: A Phase 1 Study
36. Stereotactic Body Radiation Therapy for Non-Spine Bone Metastases: A Single Institution's Experience
37. Value of MRI in Contouring Non-spine Bone Metastases for Stereotactic Body Radiation Therapy
38. Quantifying Health Utilities in Patients Undergoing Stereotactic Body Radiation Treatment for Liver Metastases for Use in Future Economic Evaluations
39. The Role of the Clinical Specialist Radiation Therapist in Delivering Person Centred Care Across the Cancer Continuum
40. Stereotactic Body Radiation Therapy in Metastatic Non-Small Cell Lung Cancer: For Oligometastases, Oligoprogression, and Local Control
41. Acute Quality of Life Changes After Stereotactic Ablative Radiation Therapy for Liver Metastasis: A Prospective Cohort Analysis
42. Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: Initial Clinical Experience
43. Post-Stereotactic Body Radiation Therapy (SBRT) Tumor Response and Inflammatory Changes as Predictors of Nonlocal Failure and Survival Outcomes in Patients With Stage I Non-Small Cell Lung Cancer (NSCLC)
44. Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma in Non-surgical Candidates: Initial Clinical Experience
45. EP-1266: Acute health-related quality of life changes after liver stereotactic ablative radiotherapy
46. Predictors of Chest Wall Toxicity after Lung Stereotactic Ablative Radiotherapy
47. A Phase 1 Trial of Stereotactic Ablative Radiation Therapy (SABR) for Oligometastatic Cancer: Toxicity and Quality of Life
48. Predictive Factors for Local Control in Primary and Metastatic Lung Tumours after Four to Five Fraction Stereotactic Ablative Body Radiotherapy: A Single Institution's Comprehensive Experience
49. Stereotactic Body Radiation Therapy (SBRT) Boost to Mimic High-Dose-Rate (HDR) Brachytherapy for Intermediate-Risk Prostate Cancer: A Phase 1 Study
50. Quality of Life in Patients Treated With Stereotactic Ablative Body Radiation Therapy (SABR) for Liver Metastases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.